Gastrin
Abbrev Code: | GASTRN | ||
Order Code: | LAB80 | Order Name: | GASTRIN |
Methodology: | Chemiluminescent immunoassay | ||
CPT Codes: | 82941 x1 | ||
Turnaround Time: | Specimens are sent to reference laboratory Mon-Sat; results are reported in 1-2 days. |
Collection Instructions
Specimen: | Blood |
Optimal Volume: | 2 mL |
Minimum\Peds Volume: | 1.2 mL |
Container: | Red or gold (gel) Alternate Containers: Red (no gel) |
Patient Preparation: | 12 hour fast recommended. |
Causes for Rejection: | Plasma and nonfrozen specimens, grossly hemolyzed or lipemic specimens. |
Processing and Shipping
Specimen Processing: | Centrifuge and aliquot 1 mL, 0.5 mL minimum. Samples are stable refrigerated for 7 days. |
Shipping Instructions: | Ship on dry ice. |
Test Performed at or Referral Lab | Lab Sendouts (ARUP) |
Referral Lab number: | 70075 (GAST) |
Interpretive
Reference Range: | 0-100 pg/mL | ||||
Use: |
Gastrin, a major gastrointestinal hormone, serves to stimulate gastric acid secretion. Gastrin testing is helpful in the identification of Zollinger-Ellison tumors (gastrinomas) and other causes of hypergastrinemia. In fasting subjects, gastrin normally circulates at levels less than 100 pg/mL. A gastrin pH less than 5.0 and a serum gastrin greater than 1000 pg/mL are virtually diagnostic of ZES. Fasting gastrin levels greater than 500 pg/mL are consistent with patients with Zollinger-Ellison syndrome (ZES), but 40% of patients with ZES have values between 100-500 pg/mL and require a stimulation test for further assessment. Most patients with Zollinger-Ellison syndrome have serum gastrin concentrations between 150-1000 pg/mL (71-475 pmol/L). Hypergastrinemia may also present in patients with normal or slightly increased gastric acid secretion, including patients with achlorhydria (atrophric gastritis or pernicious anemia), renal insufficiency, massive small bowel resection, G-cell hyperplasia, gastric outlet obstruction, and retained gastric antrum, as well as in patients receiving potent antisecretory drugs. The differentiation between Zollinger-Ellison syndrome and patients with hypergastrinemia without gastrinoma can be aided by “provocative” tests (e.g. secretion challenge or calcium infusion test). In the secretion challenge test, greater than 95% of gastrinoma patients respond to secretin infusion with a significant elevation of gastrin levels above basal levels (a rise of at least 200 pg/mL).
Secretin Stimulation Test for Diagnosis of Gastrinoma (Zollinger-Ellison Syndrome)
|
Click HERE to Report test errors or omissions.
*If no email program is associated with this computer, please contact:
systemlabguide@fairview.org for TestID: 668"